Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-hospital RBC, tranexamic acid and fibrinogen for severe trauma hemorrhage (pilot)
2018-001867-22Phase 2Completed
- Sponsor
- Banc de Sang i Teixits
- Start
- Aug 2018
- Modality
- Small Molecules, Cell Therapies, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of red blood cells, tranexamic acid and Fibrinogen human in Bleeding and trauma-induced coagulopathy (TIC) (2 arms), sponsored by Banc de Sang i Teixits. Primary endpoint: Change in TEG6s parameters defining trauma-induced coagulopathy. Started Aug 2018; status: completed.
02
Drugs
red blood cellstranexamic acidFibrinogen human
03
Conditions
Bleedingtrauma-induced coagulopathy (TIC)
Beyond the preview
Go deeper on 2018-001867-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001867-22.